Back to search
FDAFDA · Food and drugs·Recall number D-523-2013

Maxifed-G, Expectorant, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: MCR American Pharmaceuticals Inc. Brooksville, FL 34604, NDC 58605-0408-01

Published June 12, 2013 · Recall initiated: January 30, 2013

Summary

FDA records drug Class II recall D-523-2013, published June 12, 2013 and initiated January 30, 2013. Recalling firm: TG United, Inc.; Status: Terminated; Reported quantity: 1623 bottles of 100-count tablets.; Lot: Lot# 11G006 Exp. 06/13; Lot# 11K001 Exp. 09/13; Lot # 11K001 Exp. 09/13; Lot# 12C009 Exp. 02/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
TG United, Inc.
Distributor
FL, MS, SC, LA and TX
Lot
Lot# 11G006 Exp. 06/13; Lot# 11K001 Exp. 09/13; Lot # 11K001 Exp. 09/13; Lot# 12C009 Exp. 02/14.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Maxifed-G, Expectorant, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: MCR American Pharmaceuticals Inc. Brooksville, FL 34604, NDC 58605-0408-01 recalled?

Yes. FDA published recall D-523-2013 on June 12, 2013. Reported hazard: CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

What should I do if I have this product?

Voluntary: Firm initiated · Letter